Pupilometric Evaluation of Patients Under Procedural Sedation With Propofol
ALGISAP 2023
Pupilometric Evaluation of Nociception in Patients With Orthopedic Impairment Under Procedural Sedation With Propofol in the Context of the Use of the ALGISCAN Device in the Vital Emergency Department in Pasteur 2 Hospital, Nice France
1 other identifier
observational
6
1 country
1
Brief Summary
Procedural sedation involves the administration of sedative medications that allow patients to tolerate painful procedures. Procedural sedation has been formally recommended by experts from the French Society of Emergency Medicine (SFMU) since 2010 and procedural sedation using propofol in emergency departments has been recommended by the American College of Emergency Physicians in 2018. Propofol monotherapy is now widely used in emergency medicine (EM) in France as part of procedural sedation for performing painful procedures, however propofol has no analgesic properties per se . Pupilometry makes it possible to study the depth of analgesia by evaluating the body's nociceptive response via the ANS by studying the pupil diameter. This technique would allow the evaluation of the analgesia level in patients sedated by PROPOFOL during the realization of painful procedures. Variations in pupil diameter during painful procedures under procedural sedation in an emergency department will be assesed in this study. Secondly, patients satisfaction following the procedure will also be evaluated by the use of the French version of the "ISAS-F", the Iowa Satisfaction with Anesthesia Scale.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Mar 2023
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 7, 2023
CompletedFirst Posted
Study publicly available on registry
March 1, 2023
CompletedStudy Start
First participant enrolled
March 6, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
May 31, 2023
CompletedApril 8, 2025
April 1, 2025
3 months
February 7, 2023
April 7, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
pupil dilation reflex
Amplitude of pupil dilation reflex (PRD, in % change in pupil diameter)
up to 10 minutes
Secondary Outcomes (7)
Pupil diameter using the Algiscan device
up to 10 minutes
Pupil diameter variation using the Algiscan
up to 10 minutes
Heteroevaluation of the patient's maximal pain
up to 10 minutes
Patient's minimal Ramsay score
up to 10 minutes
Level of sedation
up to 10 minutes
- +2 more secondary outcomes
Study Arms (1)
Pupilometric evaluation under procedural sedation with propofol
Interventions
Pupilometric evaluation under procedural sedation with propofol
Eligibility Criteria
Adult patients admitted at vital emergency room, consecutive to an orthopedic trauma, for the performance of a painful procedure under procedural sedation with PROPOFOL.
You may qualify if:
- Adult patients
- patient admitted at vital emergency room,
- patient with an orthopedic trauma,
- patient under procedural sedation with PROPOFOL.
You may not qualify if:
- Patient's refusal of pupilometry measurement.
- Pre-existing pupil abnormalities.
- history of pathologies with dysautonomic impairment (advanced diabetes, systemic amyloidosis, multiple sclerosis, uncontrolled hypertension, ...).
- Recent administration of Metoclopramide, Droperidol, Clonidine, Dexmedetomidine
- Nitrous oxide prior to procedural sedation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Nice University Hospital
Nice, 06000, France
MeSH Terms
Conditions
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 7, 2023
First Posted
March 1, 2023
Study Start
March 6, 2023
Primary Completion
May 31, 2023
Study Completion
May 31, 2023
Last Updated
April 8, 2025
Record last verified: 2025-04
Data Sharing
- IPD Sharing
- Will not share